✦ LIBER ✦

Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma: 1985: A report from the childrens cancer study group

✍ Scribed by W. Archie Bleyer; Harland Sather; G. Denman Hammond

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 487 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860715)58:2+<590::aid-cncr2820581330>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in CNS protective treatment

Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group

✍ Tsurusawa, Masahito; Katano, Naoyuki; Yamamoto, Yoshifumi; Hirota, Takahisa; Koi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

Background. Prevention of central nervous system (CNS) leukemia by early introduction of therapy to this sanctuary site is an essential component of modern treatment strategy for acute lymphoblastic leukemia (ALL). However, the optimal form of preventive CNS therapy remains debatable. Procedure. To

Survival after relapse in childhood acut

Survival after relapse in childhood acute lymphoblastic leukemia : Impact of site and time to first relapse-the Children's Cancer Group experience

✍ Paul S. Gaynon; Roger P. Qu; Richard J. Chappell; Michael L. N. Willoughby; Davi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

other childhood cancers. The survival of patients who relapse despite improved therapy continues to be of interest.

Results of a BFM-based protocol for the

Results of a BFM-based protocol for the treatment of childhood B-non-Hodgkin's lymphoma and B-Acute lymphoblastic leukemia in Argentina

✍ Chantada, Guillermo Luis; Felice, Maria Sara; Zubizarreta, Pedro Alberto; Diaz, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Purpose: To report the feasibility and results of a study based on the bfm-all. nhl/86 protocol for b-non-hodgin's lymphoma (nhl) and b-acute lymphoblastic leukemia (b-all) in argentina. design. prospective, single arm, non-randomized trial. ## Patients and methods: From august 1988 to decembe

Treatment of patients with acute lymphob

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features : Randomized controlled trial from the Children's Cancer Group

✍ Peter G. Steinherz; Paul S. Gaynon; John C. Breneman; Joel M. Cherlow; Neil J. G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

## Background: Children with acute lymphoblastic leukemia with multiple poor prognostic factors and who have a lymphomatous mass at diagnosis, whether of t- or non-t-immunophenotype, are at increased risk of short term remission and extramedullary recurrence, and are in need of better therapies. #

A dose-intensive, cyclophosphamide-based

A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group

✍ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.